Active substanceMebeverinMebeverin
Similar drugsTo uncover
  • Veremed
    capsules inwards 
    JODAS EKSPOIM, LLC     Russia
  • Duspatalin®
    capsules inwards 
    Abbott Helskea Products BV     Netherlands
  • Duspatalin®
    pills inwards 
    Abbott Helskea Products BV     Netherlands
  • Dutane®
    capsules inwards 
  • Mebeverin
    capsules inwards 
    VERTEKS, AO     Russia
  • Mebespalin retard
    pills inwards 
    ATOLL, LLC     Russia
  • Niaspam
    capsules inwards 
  • Sparex®
    capsules inwards 
  • Talinda® retard
    capsules inwards 
    VEROPHARM SA     Russia
  • Dosage form: & nbspCapsules of prolonged action.
    Composition:One capsule contains:
    active substance: mebeverine hydrochloride 200 mg;
    Excipients: silicon colloidal dioxide 5 mg, hypromellose (hydroxypropyl methyl cellulose) 38 mg, povidone K-90 5 mg, magnesium stearate 2 mg;
    capsule hard gelatin №1: housing - titanium dioxide 1.387 mg, gelatin 44.522 mg, quinoline yellow dye 0.308 mg; dye sunset sunset yellow 0.003 mg; cap - titanium dioxide 0.893 mg, gelatin 28.686 mg, quinoline yellow color 0.199 mg; dye sunset sunset yellow 0.002 mg.
    Description:Capsules number 1 yellow. The contents of the capsules are a mixture of granules and powder of white or almost white color. Presence of lumps is allowed.
    Pharmacotherapeutic group:antispasmodic
    ATX: & nbsp

    A.03.A.A.04   Mebeverin

    A.03.A.A   Synthetic holinoblokatory - ethers with tertiary amino group

    Pharmacodynamics:Spazmolitik myotropic action, has a direct effect on the smooth muscles of the gastrointestinal tract (mainly the large intestine). Eliminates spasm without affecting normal intestinal motility. Does not possess anticholinergic action.
    Pharmacokinetics:When ingested, it undergoes pre-systemic hydrolysis and is not detected in the plasma. Metabolised in the liver to veratric acid and mebeverin alcohol. It is excreted mainly by the kidneys in the form of metabolites, in small amounts - by bile. Mebeverine capsules have a prolonged release property. Even after repeated administration, there is no significant cumulation.
    Indications:
    In adults
    Spasm of the gastrointestinal tract (including caused by organic disease), intestinal colic, biliary colic, irritable bowel syndrome.
    Children over 12 years of age
    Functional disorders of the gastrointestinal tract, accompanied by pain in the abdomen.
    Contraindications:Hypersensitivity, children's age (due to lack of data on efficacy and safety).
    Carefully:There is no information.
    Pregnancy and lactation:
    Use the drug in pregnant women with caution, if the intended benefit to the mother exceeds the potential risk to the fetus or child.
    Do not take Sparex® while breastfeeding.
    Dosing and Administration:

    Inside adults and children over 12 years 1 capsule (200 mg) 2 times a day for 20 minutes before meals (morning and evening). Swallow whole with water.

    Side effects:Dizziness, headache, diarrhea, constipation.
    Allergic reactions: urticaria, Quincke's edema, edema of the face and exanthema.
    Overdose: Symptoms: excitation of the central nervous system.
    The specific antidote is unknown. Recommended gastric lavage and symptomatic therapy.
    Interaction:There is no information.
    Effect on the ability to drive transp. cf. and fur:During the treatment period, care should be taken when driving vehicles and during classes with potentially dangerous activities that require an increased concentration of attention and speed of psychomotor reactions.
    Form release / dosage:Capsules of prolonged action, 200 mg.
    Packaging:For 10 or 15 capsules in a contour mesh box made of polyvinylchloride film and aluminum foil printed lacquered.
    For 1, 3, 6 contour cell packs of 10 capsules or 2, 4 contourcell packs of 15 capsules together with instructions for use in a pack of cardboard.
    Storage conditions:Store in a dry, dark place at a temperature of no higher than 25 ° C.
    Keep out of the reach of children.
    Shelf life:
    2 years.
    Do not use at the expiration date.
    Terms of leave from pharmacies:On prescription
    Registration number:LSR-004416/09
    Date of registration:04.06.2009 / 27.04.2015
    Expiration Date:Unlimited
    The owner of the registration certificate:CANONFARMA PRODUCTION, CJSC CANONFARMA PRODUCTION, CJSC Russia
    Manufacturer: & nbsp
    Representation: & nbspCANONFARMA PRODUCTION CJSC CANONFARMA PRODUCTION CJSC Russia
    Information update date: & nbsp20.08.2016
    Illustrated instructions
      Instructions
      Up